Garde Capital’s Core Scientific CORZ Stock Holding History

Garde Capital’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-6	Closed	-$103	–	367
2025 Q2	$103	Hold	6	–	–	﹤0.01%	815
2025 Q1	$44	Buy	+6	New	+$68	﹤0.01%	819

Other funds holding CORZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Situational Awareness San Francisco, California $13.7B AUM 334.5% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

JCAM

Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OWP

ORG Wealth Partners Dallas, Texas $508M AUM 83.62% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Garde Capital's CORZ Position: Q3 2025 in Review

Garde Capital sold out of Core Scientific (CORZ) in Q3 2025, closing a stake of 6 shares — an estimated $103 sold.

Garde Capital first reported a position in CORZ in Q1 2025 and held it in 2 quarters. The position peaked at $103 in Q2 2025. 336 funds tracked by Wall St. Rank hold CORZ as of Q3 2025.

Garde Capital reported no remaining Core Scientific position as of Q3 2025 after selling out during the quarter.
Garde Capital sold 6 Core Scientific shares in Q3 2025, an estimated $103.
Garde Capital first reported a position in Core Scientific in Q1 2025 and held it in 2 quarters.
Garde Capital's Core Scientific position peaked at $103 in Q2 2025.
336 funds tracked by Wall St. Rank held Core Scientific as of Q3 2025.

Based on Garde Capital's 13F filing for Q3 2025, filed 16 Dec 2025.